Toth Financial Advisory Corp Boosts Stock Position in CVS Health Corporation $CVS

Toth Financial Advisory Corp lifted its holdings in shares of CVS Health Corporation (NYSE:CVS) by 24.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 89,591 shares of the pharmacy operator’s stock after buying an additional 17,784 shares during the quarter. Toth Financial Advisory Corp’s holdings in CVS Health were worth $7,110,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. SOA Wealth Advisors LLC. increased its position in CVS Health by 36.9% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after acquiring an additional 131 shares during the period. Alteri Wealth LLC lifted its position in CVS Health by 3.2% during the 3rd quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock worth $316,000 after acquiring an additional 131 shares during the period. Holistic Financial Partners lifted its position in CVS Health by 4.1% during the 3rd quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator’s stock worth $256,000 after acquiring an additional 133 shares during the period. CYBER HORNET ETFs LLC grew its stake in shares of CVS Health by 4.1% in the 3rd quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator’s stock valued at $259,000 after purchasing an additional 134 shares during the last quarter. Finally, Fayez Sarofim & Co increased its holdings in shares of CVS Health by 2.1% in the third quarter. Fayez Sarofim & Co now owns 6,913 shares of the pharmacy operator’s stock valued at $521,000 after purchasing an additional 140 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Morgan Stanley increased their price target on CVS Health from $89.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. Piper Sandler dropped their price objective on shares of CVS Health from $101.00 to $99.00 and set an “overweight” rating on the stock in a research note on Tuesday. Bank of America reduced their target price on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a research note on Tuesday, January 27th. Truist Financial set a $100.00 target price on shares of CVS Health in a report on Wednesday, December 10th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a research note on Wednesday, December 10th. Twenty research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and an average target price of $94.95.

CVS Health Stock Performance

NYSE CVS opened at $73.57 on Friday. The business has a 50 day moving average price of $75.74 and a 200 day moving average price of $77.68. The company has a market capitalization of $93.59 billion, a P/E ratio of 53.31, a PEG ratio of 0.77 and a beta of 0.51. CVS Health Corporation has a 1-year low of $58.35 and a 1-year high of $85.15. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63.

CVS Health (NYSE:CVS) last posted its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. During the same period in the previous year, the business earned $1.19 earnings per share. CVS Health’s quarterly revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Sell-side analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.6%. The ex-dividend date is Thursday, April 23rd. CVS Health’s dividend payout ratio (DPR) is 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.